Siegfried Appoints Eduardo Montanha as COO to Drive Integrated Operations Strategy

Siegfried (SIX: SFZN), a global Contract Development and Manufacturing Organization (CDMO), announced the appointment of Eduardo Montanha as Chief Operating Officer and member of the Executive Committee, effective September 1, 2026. The move follows the company's decision to merge the Chief Operating Officer roles for Drug Substances and Drug Products into a single position, supporting Siegfried's strategy to offer integrated end-to-end solutions across the pharmaceutical value chain.

Eduardo Montanha brings more than 20 years of international leadership experience in pharmaceutical and biopharmaceutical manufacturing. Most recently, he served as Executive Vice President, Head of Global Technical Operations & Quality at Fresenius Kabi, where he led an integrated global network of around 30 manufacturing sites across multiple regions. Earlier in his career, he held senior leadership positions at Takeda, Sandoz, Hexal, and Hoechst/Aventis, covering technical operations, quality, supply, and large-scale manufacturing networks.

With his strong track record in integrated operations, Montanha will focus on further strengthening supply performance, operational efficiency and reliability across Siegfried's global network. The company operates 16 sites in Switzerland, Germany, Spain, France, Malta, the USA, Australia and China, and in 2025 achieved sales of CHF 1,327.8 million with over 3,800 employees.

Marcel Imwinkelried, Chief Executive Officer of Siegfried, stated: "I am very pleased to welcome Eduardo to Siegfried. He brings outstanding global operations and quality leadership experience and will play an important role in further enhancing supply performance, operational efficiency and reliability for our customers."

Montanha holds a bachelor's degree in chemical engineering, a postgraduate qualification in Industrial Automation, and an MBA in Project Management. He has lived and worked across Europe and Latin America, adding valuable international perspective to the executive team.

The appointment underscores Siegfried's commitment to streamlining operations and delivering comprehensive solutions, from drug substances to drug products, as outlined in its strategic vision. For more information, visit www.siegfried.ch.